The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and elexacaftor) and Kalydeco (ivacaftor) for children aged two to five years old.
Head injuries resulted in 142,000 admitted hospital cases in 2020-21 - the equivalent of 1 hospitalization every 4 minutes, according to a report released by the Australian Institute of Health and Welfare (AIHW).
An increasing number of studies have found a significant link between higher cholesterol levels in midlife and Alzheimer's disease and dementia in later life. Swap fatty foods for healthier options this Christmas and get tested now, says a leading testing expert.
Loughborough University is collaborating with NHS England to deliver learning to hundreds of healthcare professionals in a bid to improve patient safety.